cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Design Therapeautics Inc
4 own
2 watching
Current Price
$0
$-0.08
(-1.43%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
312.59M
52-Week High
52-Week High
26.3
52-Week Low
52-Week Low
4.9
Average Volume
Average Volume
0M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization312.59M
icon52-Week High26.3
icon52-Week Low4.9
iconAverage Volume0M
iconDividend Yield--
iconP/E Ratio--
What does the Design Therapeautics Inc do?
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company s portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function, eventually leading to neurological, cardiac, and metabolic dysfunction; and Myotonic Dystrophy Type-1 (DM1), a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs. It is also developing GeneTAC product candidate portfolio for the treatment of other nucleotide repeat expansion-driven monogenic diseases, such as Fragile X syndrome, spinocerebellar ataxias, amyotrophic lateral sclerosis, frontotemporal dementia, Huntington disease, and spinobulbar muscular atrophy. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.
Read More
How much money does Design Therapeautics Inc make?
News & Events about Design Therapeautics Inc.
PR Newswire
5 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Design Therapeutics, Inc. - DSGN SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Design Therapeutics, Inc. - DSGN PR Newswire NEW YORK, Jan. 4, 2023 NEW YORK, Jan. 4, 2023...
Globe Newswire
5 months ago
NEW YORK, Dec. 30, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Design Therapeutics, Inc. (Design or the Company) (NASDAQ: DSGN) on behalf of Design stockholders. Our investigation concerns ...
Globe Newswire
5 months ago
NEW YORK, Dec. 24, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Design Therapeutics, Inc. (Design or the Company) (NASDAQ:DSGN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The ...
Ticker Report
5 months ago
Design Therapeutics, Inc. (NASDAQ:DSGN Get Rating) Director Simeon George purchased 360,000 shares of the stock in a transaction dated Monday, December 19th. The stock was acquired at an average cost of $8.63 per share, for a total transaction of $3,106,800.00. Following the completion of ...
Ticker Report
5 months ago
Design Therapeutics, Inc. (NASDAQ:DSGN Get Rating) Director Simeon George acquired 500,000 shares of the businesss stock in a transaction dated Friday, December 16th. The shares were bought at an average price of $8.28 per share, for a total transaction of $4,140,000.00. Following the...
Frequently Asked Questions
Frequently Asked Questions
What is Design Therapeautics Inc share price today?
plus_minus_icon
Can Indians buy Design Therapeautics Inc shares?
plus_minus_icon
How can I buy Design Therapeautics Inc shares from India?
plus_minus_icon
Can Fractional shares of Design Therapeautics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Design Therapeautics Inc stocks?
plus_minus_icon
What is today’s traded volume of Design Therapeautics Inc?
plus_minus_icon
What is today’s market capitalisation of Design Therapeautics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Design Therapeautics Inc?
plus_minus_icon
What percentage is Design Therapeautics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Design Therapeautics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$-0.08
(-1.43%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
SUTRO BIOPHARMA INC
SUTRO BIOPHARMA INC
$5.18
$0.05 (1.07 %)
SCHOLAR ROCK HOLDING CORP
SCHOLAR ROCK HOLDING CORP
$7.08
$0.14 (2.02 %)
OLEMA PHARMACEUTICALS INC
OLEMA PHARMACEUTICALS INC
$7.13
$0.58 (8.85 %)
INOZYME PHARMA INC
INOZYME PHARMA INC
$6.09
$0.13 (2.10 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
SUTRO BIOPHARMA INC
SUTRO BIOPHARMA INC
$5.18
$0.05 (1.07 %)
SCHOLAR ROCK HOLDING CORP
SCHOLAR ROCK HOLDING CORP
$7.08
$0.14 (2.02 %)
OLEMA PHARMACEUTICALS INC
OLEMA PHARMACEUTICALS INC
$7.13
$0.58 (8.85 %)
INOZYME PHARMA INC
INOZYME PHARMA INC
$6.09
$0.13 (2.10 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00